Literature DB >> 21753025

Sex differences in the inflammatory mediator-induced sensitization of dural afferents.

N N Scheff1, M S Gold.   

Abstract

Approximately 20% of the adult population suffers from migraine. This debilitating pain disorder is three times more prevalent in women than in men. To begin to evaluate the underlying mechanisms that may contribute to this sex difference, we tested the hypothesis that there is a sex difference in the inflammatory mediator (IM)-induced sensitization of dural afferents. Acutely dissociated retrogradely labeled dural afferents from adult Sprague-Dawley rats were examined with whole cell patch-clamp recordings. Baseline passive and active electrophysiological properties of dural afferents from both sexes were comparable. However, while IM-induced increases in the excitability of dural afferents from male and female rats were also comparable, the proportion of dural afferents from female rats sensitized by IM (~100%) was significantly greater than that of dural afferents from male rats (~50%). This appeared to be due to differences downstream of IM receptors, as tetrodotoxin-resistant sodium current was increased by IM in a majority of male dural afferents (13/14). These data indicate that there are both quantitative and qualitative differences in the IM-induced sensitization of dural afferents that may contribute to the sex difference in the manifestation of migraine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21753025      PMCID: PMC3191837          DOI: 10.1152/jn.00196.2011

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  44 in total

1.  Lidocaine toxicity in primary afferent neurons from the rat.

Authors:  M S Gold; D B Reichling; K F Hampl; K Drasner; J D Levine
Journal:  J Pharmacol Exp Ther       Date:  1998-05       Impact factor: 4.030

Review 2.  Pharmacology of peripheral neuropeptide and inflammatory mediator release.

Authors:  K M Hargreaves; J Q Swift; M T Roszkowski; W Bowles; M G Garry; D L Jackson
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1994-10

3.  Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors.

Authors:  W F Stewart; R B Lipton; D D Celentano; M L Reed
Journal:  JAMA       Date:  1992-01-01       Impact factor: 56.272

Review 4.  Tetrodotoxin-resistant Na+ currents and inflammatory hyperalgesia.

Authors:  M S Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

5.  Peptidergic and serotoninergic innervation of the rat dura mater.

Authors:  J T Keller; C F Marfurt
Journal:  J Comp Neurol       Date:  1991-07-22       Impact factor: 3.215

6.  Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs.

Authors:  J Longmore; D Shaw; D Smith; R Hopkins; G McAllister; J D Pickard; D J Sirinathsinghji; A J Butler; R G Hill
Journal:  Cephalalgia       Date:  1997-12       Impact factor: 6.292

7.  Sensitization of meningeal sensory neurons and the origin of headaches.

Authors:  A M Strassman; S A Raymond; R Burstein
Journal:  Nature       Date:  1996-12-12       Impact factor: 49.962

8.  Role of a Ca(2+)-dependent slow afterhyperpolarization in prostaglandin E2-induced sensitization of cultured rat sensory neurons.

Authors:  M S Gold; M J Shuster; J D Levine
Journal:  Neurosci Lett       Date:  1996-03-01       Impact factor: 3.046

9.  Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors.

Authors:  M S Gold; D B Reichling; M J Shuster; J D Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

10.  Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor.

Authors:  P G Mermelstein; J B Becker; D J Surmeier
Journal:  J Neurosci       Date:  1996-01-15       Impact factor: 6.167

View more
  9 in total

1.  Female sex and obesity increase photophobic behavior in mice.

Authors:  Heather L Rossi; Orlando Lara; Ana Recober
Journal:  Neuroscience       Date:  2016-06-17       Impact factor: 3.590

2.  The properties, distribution and function of Na(+)-Ca(2+) exchanger isoforms in rat cutaneous sensory neurons.

Authors:  N N Scheff; E Yilmaz; M S Gold
Journal:  J Physiol       Date:  2014-09-19       Impact factor: 5.182

3.  Contribution of tetrodotoxin-resistant persistent Na+ currents to the excitability of C-type dural afferent neurons in rats.

Authors:  Michiko Nakamura; Il-Sung Jang
Journal:  J Headache Pain       Date:  2022-06-28       Impact factor: 8.588

Review 4.  Ion channels and migraine.

Authors:  Jin Yan; Gregory Dussor
Journal:  Headache       Date:  2014-04       Impact factor: 5.887

5.  Inflammatory Pain Reduces C Fiber Activity-Dependent Slowing in a Sex-Dependent Manner, Amplifying Nociceptive Input to the Spinal Cord.

Authors:  Allen C Dickie; Barry McCormick; Veny Lukito; Kirsten L Wilson; Carole Torsney
Journal:  J Neurosci       Date:  2017-06-02       Impact factor: 6.167

6.  Can we define migraine patients with blood high-sensitivity C-reactive protein and galectin-3 levels in the emergency department?

Authors:  Mehtap Gürger; Metin Atescelik; Mustafa Yilmaz; Mustafa Yildiz; Hatice Kalayci; Mehmet Ali Kobat; Caner Fevzi Demir
Journal:  Arch Med Sci       Date:  2016-06-30       Impact factor: 3.318

Review 7.  Animal models of migraine and experimental techniques used to examine trigeminal sensory processing.

Authors:  Andrea M Harriott; Lauren C Strother; Marta Vila-Pueyo; Philip R Holland
Journal:  J Headache Pain       Date:  2019-08-29       Impact factor: 7.277

Review 8.  Could Experimental Inflammation Provide Better Understanding of Migraines?

Authors:  Philip Victor Reducha; Lars Edvinsson; Kristian Agmund Haanes
Journal:  Cells       Date:  2022-08-06       Impact factor: 7.666

Review 9.  Sex-Specific Pharmacotherapy for Migraine: A Narrative Review.

Authors:  Parisa Gazerani; Brian E Cairns
Journal:  Front Neurosci       Date:  2020-03-20       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.